Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IMVT
IMVT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IMVT News
HCW Biologics Stock Surges 129% Amid Concerns
May 21 2026
NASDAQ.COM
Immunovant Stock Hits Five-Year High Following Positive Trial Results
May 21 2026
Yahoo Finance
IMVT-1402 Phase 2 Data Shows Strong Response Rates
May 20 2026
stocktwits
Immunovant's Phase 2 Trial Results Show Promising Efficacy for IMVT-1402
May 20 2026
seekingalpha
Immunovant Reports Fiscal 2026 Financial Results and Updates on IMVT-1402
May 20 2026
NASDAQ.COM
Immunovant Q4 Earnings Miss Expectations with Significant Cash Reserves
May 20 2026
seekingalpha
Immunovant Set to Announce Q4 Earnings on May 20
May 19 2026
seekingalpha
Biotech Landscape Update: Regulatory Approvals and Acquisitions
Apr 03 2026
NASDAQ.COM
US Stocks Plummet as Oil Prices Surge
Apr 02 2026
NASDAQ.COM
Immunovant Reports Disappointing Trial Results, Shares Drop
Apr 02 2026
stocktwits
Immunovant's Phase 3 Trials Fail to Meet Primary Endpoints
Apr 02 2026
NASDAQ.COM
Immunovant Shares Drop 10% After Batoclimab Trial Failure
Apr 02 2026
seekingalpha
Logos Increases Immunovant Stake to $35 Million
Mar 15 2026
NASDAQ.COM
Logos Global Management Increases Immunovant Stake to 1.375 Million Shares
Mar 15 2026
Fool
S&P 500 Futures Rise in Pre-Market Session; Adobe and Ulta Beauty Underperform
Mar 13 2026
Barron's
Alpine Global Management Reduces Immunovant Holdings
Mar 11 2026
Fool
Show More News
